Health Decisions, a full-service contract research organization that specializes in women's health clinical research and diagnostic development, has announced that Dr. Mary Gunn will serve as its new Chief Operating Officer.
As COO, Dr. Gunn will oversee all client-facing operations, including Biostatistics & Programming, Clinical Operations, and Data Management.
Before joining Health Decisions, Dr. Gunn was VP, General Management and Business Development, and Head of Asia at ICON. Dr. Gunn has also held leadership roles at Becton Dickinson, ClinTec International, Crucell, and Pfizer.
In a press release, Health Decisions CEO Dr. Patrick Phillips said, "We are delighted to add Dr. Gunn to our strategic leadership team. Her track record of enhancing operational delivery platforms and enabling successful clinical program execution will help elevate the services that we provide to Sponsors. Dr. Gunn is an excellent addition to the team and our commitment to being the foremost clinical development service company across women's health and diagnostic services.”
Dr. Gunn stated, "I am honored to join the Health Decisions team and support the creation of much-needed healthcare solutions for women. There continues to be tremendous innovation in women's health, and I look forward to building on Health Decisions' proven capabilities to enhance operational agility as we help Sponsors navigate the evolving clinical and regulatory environment."